Trial Identifier: | D3560C00088 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02433288 |
Start Date: | July 2015 |
Primary Completion Date: | October 2016 |
Study Completion Date: | October 2016 |
Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China | beijing, China, 100191 |
China | Beijing, China, 100049 |
China | Beijing, China, 100700 |
China | Beijing, China, 100730 |
China | Beijing, China, 101199 |
China | Beijing, China, 100029 |
China | Beijing, China, 100034 |
China | Beijing, China, 100045 |
China | changsha, China, 410005 |
China | Chengdu, China, 610041 |
China | Chongqing, China, 400013 |
China | Hang Zhou, China, 310003 |
China | Huzhou, China, 313003 |
China | Nanchang, China, 330009 |
China | Shandong, China, 262700 |
China | Shanghai, China, 200050 |
China | Shanghai, China, 200240 |
China | Shanghai, China, 201199 |
China | Shanghai, China, 200072 |
China | Tianjin, China, 300192 |
China | Tianjin, China, 300211 |
China | Tianjin, China, 300142 |
China | Waifang, China, 261500 |
China | Wenzhou, China, 325000 |
China | wuhan, China, 430022 |